Hims & Hers DCF Valuation: Intrinsic Value Calculator

Hims & Hers is a telehealth platform delivering personalized treatments for sexual health, hair loss, mental health, and weight management via an online subscription model. Gross margins are approximately 73%, reflecting the high-margin direct-to-consumer model. Revenue growth has recently moderated as the company faces regulatory uncertainty around compounded GLP-1 prescriptions, which drove significant subscriber growth. Key assumptions: the core men's and women's health subscription base continues mid-to-high-teens growth, the weight management category (semaglutide and tirzepatide treatments) provides a durable growth driver, and the company reaches sustained operating profitability as subscriber scale leverages the fixed platform cost structure.